Clinical Trial Update: INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections [Phase 3]

View source ↗

Summary

Phase 3 trial update for the INTERCEPT Blood System for Red Blood Cells in regions at risk for Zika virus transfusion-transmitted infections; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• INTERCEPT Blood System for RBCs

Snippet

Sponsor: Cerus Corporation | Conditions: Anemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING